Browsing by Author Zagorianakou, N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 19 of 19
TitleAuthor(s)Issue date
CD44 family and gynaecological cancerMakrydimas, G.; Zagorianakou, N.; Zagorianakou, P.; Agnantis, N. J.24-Nov-2015
CD44s expression, in benign, borderline and malignant tumors of ovarian surface epithelium. Correlation with p53, steroid receptor status, proliferative indices (PCNA, MIB1) and survivalZagorianakou, N.; Stefanou, D.; Makrydimas, G.; Zagorianakou, P.; Briasoulis, E.; Karavasilis, B.; Agnantis, N. J.24-Nov-2015
Clinical correlation of bone marrow microvessel density in essential thrombocythemiaPanteli, K.; Zagorianakou, N.; Agnantis, N. J.; Bourantas, K. L.; Bai, M.24-Nov-2015
Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumorsZagorianakou, N.; Stefanou, D.; Makrydimas, G.; Zagorianakou, P.; Briasoulis, E.; Karavasilis, V.; Pavlidis, N.; Agnantis, N. J.24-Nov-2015
Coelomic cells show apoptosis via Fas/FasL system: a comparative study between healthy human pregnancies and missed miscarriagesKaponis, A.; Skyrlas, A.; Zagorianakou, N.; Georgiou, I.; Passa, V.; Paraskevaidis, E.; Makrydimas, G.24-Nov-2015
Complete hydatidiform mole and normal live birth: a novel case of confined placental mosaicism: case reportMakrydimas, G.; Sebire, N. J.; Thornton, S. E.; Zagorianakou, N.; Lolis, D.; Fisher, R. A.24-Nov-2015
The enigmatic nature of apocrine breast lesionsZagorianakou, P.; Zagorianakou, N.; Stefanou, D.; Makrydimas, G.; Agnantis, N. J.24-Nov-2015
Expression of dysadherin and E-cadherin in trophoblastic tissue in normal and abnormal pregnanciesBatistatou, A.; Makrydimas, G.; Zagorianakou, N.; Zagorianakou, P.; Nakanishi, Y.; Agnantis, N. J.; Hirohashi, S.; Charalabopoulos, K.24-Nov-2015
Expression of the cell-cycle regulatory proteins (cyclins D1 and E) in endometrial carcinomas: correlations with hormone receptor status, proliferating indices, tumor suppressor gene products (p53, pRb), and clinicopathological parametersMitselou, A.; Ioachim, E.; Zagorianakou, N.; Kitsiou, E.; Vougiouklakis, T.; Agnantis, N. J.24-Nov-2015
FNAC: its role, limitations and perspective in the preoperative diagnosis of breast cancerZagorianakou, P.; Fiaccavento, S.; Zagorianakou, N.; Makrydimas, G.; Stefanou, D.; Agnantis, N. J.24-Nov-2015
Glycoprotein CD44 expression in normal, hyperplasic and neoplastic endometrium. An immunohistochemical study including correlations with p53, steroid receptor status and proliferative indices (PCNA, MIB1)Zagorianakou, N.; Ioachim, E.; Mitselou, A.; Kitsou, E.; Zagorianakou, P.; Stefanaki, S.; Makrydimas, G.; Agnantis, N. J.24-Nov-2015
Immunohistochemical evaluation of cathepsin D in normal, hyperplastic and malignant endometrium: correlation with hormone receptor status c-erbB-2, p53, Rb proteins and proliferation associated indicesIoachim, E.; Kitsiou, E.; Charalabopoulos, K.; Mitselou, A.; Zagorianakou, N.; Makrydimas, G.; Tzioras, S.; Salmas, M.24-Nov-2015
Immunohistochemical expression of heat shock protein 27, in normal hyperplastic and neoplastic endometrium: correlation with estrogen and progesterone receptor status, p53, pRb and proliferation associated indices (PCNA, MIB1)Zagorianakou, N.; Ioachim, E.; Mitselou, A.; Kitsou, E.; Zagorianakou, P.; Makrydimas, G.; Salmas, M.; Agnantis, N. J.24-Nov-2015
Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometriumMitselou, A.; Ioachim, E.; Kitsou, E.; Vougiouklakis, T.; Zagorianakou, N.; Makrydimas, G.; Stefanaki, S.; Agnantis, N. J.24-Nov-2015
Microvessel density and immunohistochemical expression of the angiogenic proteins VEGF, VEGFR1 and VEGFR2 in normal, hyperplastic and neoplastic endometriumZagorianakou, N.; Goussia, A.; Zagorianakou, P.; Pakos, E.; Tsekeris, P.; Nesseris, I.; Malamou-Mitsi, V.; Agnantis, N. J.; Bai, M.24-Nov-2015
P21(waf1/cip1) protein expression in normal, hyperplastic and malignant endometrium. Correlation with hormone receptor status, c-erbB-2 oncoprotein, bcl-2 and other cell cycle related proteins (Rb, p53, Ki-67, PCNA)Ioachim, E.; Kitsiou, E.; Mitselou, A.; Zagorianakou, N.; Charalabopoulos, K.; Salmas, M.; Makrydimas, G.; Vougiouklakis, T.; Agnantis, N. J.24-Nov-2015
Prognostic significance of p53 in the cancer of the larynxAssimakopoulos, D.; Kolettas, E.; Zagorianakou, N.; Evangelou, A.; Skevas, A.; Agnantis, N. J.24-Nov-2015
The role of fine-needle aspiration biopsy in the management of patients with thyroid nodulesZagorianakou, P.; Malamou-Mitsi, V.; Zagorianakou, N.; Stefanou, D.; Tsatsoulis, A.; Agnantis, N. J.24-Nov-2015
Updated diagnostic criteria for partial and complete hydatidiform moles in early pregnancySebire, N. J.; Makrydimas, G.; Agnantis, N. J.; Zagorianakou, N.; Rees, H.; Fisher, R. A.24-Nov-2015